Rhythmic Auditory Stimulation & Gait Training
A Pilot Single-blind Randomized Controlled Trial to Evaluate the Safety and Feasibility of Rhythmic Auditory Stimulation for Gait Training in Persons With Multiple Sclerosis
1 other identifier
interventional
24
1 country
1
Brief Summary
This study will enroll patients with Multiple Sclerosis and some difficulty with walking. The purpose of this study is to use Rhythmic Auditory Stimulation (RAS) a music therapy technique that provides rhythmic auditory cues (like a beat) to help improve a patient's movements, especially when walking. Participants will be asked to participate in a walking program (WP) with Rhythmic Auditory Stimulation (RAS), or a WP without RAS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable multiple-sclerosis
Started Jun 2020
Typical duration for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2020
CompletedFirst Posted
Study publicly available on registry
March 18, 2020
CompletedStudy Start
First participant enrolled
June 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 7, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 7, 2022
CompletedFebruary 9, 2023
February 1, 2023
2.4 years
March 11, 2020
February 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of patients with adverse events
Adverse events will be collected throughout the study period to assess treatment safety.
through study completion, up to 16 weeks
Percentage of training sessions missed.
Training session attendance will be tracked as an indicator of feasibility throughout the treatment period.
through end of treatment, up to 9 weeks
Secondary Outcomes (4)
Timed 25 Foot Walk
Week 0, Week 9 and week 16
6-Minute Walk
Week 0, Week 9 and week 16
Spatiotemporal gait parameters
Week 0, Week 9 and week 16
MS Walking Scale - 12
Week 0, Week 9 and week 16
Study Arms (2)
Gait Training (GT) with Rhythmic Auditory Stimulation (RAS)
ACTIVE COMPARATORParticipants in this arm will complete 16 supervised gait training sessions consisting of continuous overground walking on a track for 30 minutes,with RAS
Gait training (GT) without Rhythmic Auditory Stimulation (RAS)
OTHERParticipants in this arm will complete 16 supervised gait training sessions consisting of continuous overground walking on a track for 30 minutes without RAS
Interventions
RAS, a Neurologic Music Therapy technique developed to utilize rhythm and timing cues to assist in improving the basic, intrinsic rhythmic movements of gait.
Continuous overground walking on a track for 30 minutes. Gait training will primarily consist of walking exercise under the supervision of an exercise physiologist.
Eligibility Criteria
You may qualify if:
- Diagnosis of MS based on 2017 revised McDonald criteria (relapsing or progressive course)
- Performs the T25FW in 8 to 30 seconds (cane(s), walking stick(s), crutch(es), or wheeled walker allowed)
You may not qualify if:
- Physical therapy in the past 3 months or immediate need for PT due to safety concerns (e.g. falls)
- Requires at least one seated rest during the 6 MW test
- Treatment with high-dose corticosteroids in the past 2 months or planned during the study period
- Lower extremity botulinum toxin (BT) injections for spasticity in the past 3 months, or planned during the study period
- Initiation of an oral symptomatic therapy which could affect walking in the past 4 weeks (particularly dalfampridine and medications for spasticity)
- Initiation of a new disease-modifying therapy for MS in the past 3 months
- Comorbidity compromising safe participation or affecting walking (e.g. uncontrolled cardiac or respiratory illness, musculoskeletal disorder)
- Severe hearing impairment with or without the use of hearing aids, such that the participant cannot hear the rhythmic music stimulus consistently.
- Inability to walk safely to the rhythmic music stimulus during the baseline visit.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Cleveland Cliniclead
- Consortium of Multiple Sclerosis Centerscollaborator
- MedRhythms, Inc.collaborator
Study Sites (1)
Cleveland Clinic
Cleveland, Ohio, 44195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francois Bethoux, MD
The Cleveland Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- A blinded examiner will be used to perform the gait analysis, 6 minute walk , and timed 25 foot walk
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chairman, Department of PM&R,
Study Record Dates
First Submitted
March 11, 2020
First Posted
March 18, 2020
Study Start
June 8, 2020
Primary Completion
November 7, 2022
Study Completion
November 7, 2022
Last Updated
February 9, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share